BIOGEN INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q1 2022

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Biogen Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q1 2022.
Biogen Inc. Operating Income (Loss) for the quarter ending March 31, 2022 was $611M, a 37.3% decline year-over-year.
Biogen Inc. Operating Income (Loss) for the twelve months ending March 31, 2022 was $2.48B, a 33.1% decline year-over-year.
Biogen Inc. annual Operating Income (Loss) for 2021 was $2.84B, a 37.6% decline from 2020.
Biogen Inc. annual Operating Income (Loss) for 2020 was $4.55B, a 35.4% decline from 2019.
Biogen Inc. annual Operating Income (Loss) for 2019 was $7.04B, a 19.6% increase from 2018.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2022	$2.48B	$611M	-$363M	-37.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2022-05-03
Q4 2021	$2.84B	$587M	+$918M		Oct 1, 2021	Dec 31, 2021	10-K	2022-02-03
Q3 2021	$1.92B	$794M	-$292M	-26.9%	Jul 1, 2021	Sep 30, 2021	10-Q	2021-10-20
Q2 2021	$2.22B	$486M	-$1.49B	-75.4%	Apr 1, 2021	Jun 30, 2021	10-Q	2021-07-22
Q1 2021	$3.7B	$974M	-$846M	-46.5%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-03
Q4 2020	$4.55B	-$331M	-$2.11B	-119%	Oct 1, 2020	Dec 31, 2020	10-K	2022-02-03
Q3 2020	$6.66B	$1.09B	-$720M	-39.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-10-20
Q2 2020	$7.38B	$1.97B	+$18.6M	+0.95%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-22
Q1 2020	$7.36B	$1.82B	+$317M	+21.1%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-22
Q4 2019	$7.04B	$1.78B	+$335M	+23.2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-03
Q3 2019	$6.71B	$1.81B	+$109M	+6.4%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-10-21
Q2 2019	$6.6B	$1.96B	+$743M	+61.2%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-22
Q1 2019	$5.86B	$1.5B	-$32M	-2.09%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-04-23
Q4 2018	$5.89B	$1.44B	-$23.1M	-1.58%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-03
Q3 2018	$5.91B	$1.7B	+$43.7M	+2.64%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-10-22
Q2 2018	$5.87B	$1.21B	+$12.2M	+1.02%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-07-24
Q1 2018	$5.86B	$1.53B	+$510M	+49.8%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-04-24
Q4 2017	$5.35B	$1.47B	+$579M	+65.2%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-06
Q3 2017	$4.77B	$1.65B	+$229M	+16%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-10-23
Q2 2017	$4.54B	$1.2B	-$260M	-17.8%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-07-24
Q1 2017	$4.8B	$1.02B	-$354M	-25.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-04-24
Q4 2016	$5.15B	$888M	-$281M	-24%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-06
Q3 2016	$5.43B	$1.43B	+$53.5M	+3.9%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-10-24
Q2 2016	$5.38B	$1.46B	+$227M	+18.4%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-07-25
Q1 2016	$5.15B	$1.38B	+$261M	+23.3%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-04-25
Q4 2015	$4.89B	$1.17B	+$8.45M	+0.73%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-01
Q3 2015	$4.88B	$1.37B	+$219M	+19%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-10-26
Q2 2015	$4.66B	$1.23B	+$244M	+24.7%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-07-21
Q1 2015	$4.42B	$1.12B	+$447M	+66.5%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-04-21
Q4 2014	$3.97B	$1.16B	+$502M	+76.3%	Oct 1, 2014	Dec 31, 2014	10-K	2017-02-02
Q3 2014	$3.47B	$1.15B	+$468M	+68.4%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-10-21
Q2 2014	$3B	$989M	+$326M	+49.2%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-07-24
Q1 2014	$2.68B	$671M	+$161M	+31.5%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-04-24
Q4 2013	$2.52B	$658M	+$212M	+47.7%	Oct 1, 2013	Dec 31, 2013	10-K	2016-02-03
Q3 2013	$2.3B	$685M	+$149M	+27.9%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-10-22
Q2 2013	$2.15B	$663M	+$157M	+31%	Apr 1, 2013	Jun 30, 2013	10-Q	2014-07-23
Q1 2013	$2B	$511M	+$141M	+38.2%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-04-23
Q4 2012	$1.86B	$446M	+$36.4M	+8.9%	Oct 1, 2012	Dec 31, 2012	10-K	2015-02-04
Q3 2012	$1.82B	$535M	+$46.8M	+9.57%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-10-28
Q2 2012	$1.77B	$506M	+$94.9M	+23.1%	Apr 1, 2012	Jun 30, 2012	10-Q	2013-07-25
Q1 2012	$1.68B	$369M	-$46.9M	-11.3%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-04-25
Q4 2011	$1.72B	$409M	+$53.9M	+15.2%	Oct 1, 2011	Dec 31, 2011	10-K	2014-02-06
Q3 2011	$1.67B	$488M	+$294M	+152%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-10-25
Q2 2011	$1.38B	$411M	+$14.9M	+3.77%	Apr 1, 2011	Jun 30, 2011	10-Q	2012-07-24
Q1 2011	$1.36B	$416M	+$113M	+37.1%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-01
Q4 2010	$1.25B	$355M			Oct 1, 2010	Dec 31, 2010	10-K	2013-02-05
Q3 2010		$194M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-10-28
Q2 2010		$396M			Apr 1, 2010	Jun 30, 2010	10-Q	2011-07-26
Q1 2010		$304M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-04-21

* An asterisk sign (*) next to the value indicates that the value is likely invalid.